Chronic Lithium Use Need Not Always Be "Chronic"

Introduction: Lithium induced nephropathy is typically considered to be a slowly progressive kidney disease with a reported latency period of 20 years from initiation of lithium to ESKD. Here, we present a case of progressive CKD within 2 years of initiation of lithium for bipolar disorder. Case Description: 22-year-old female with bipolar disorder and ADHD was referred to renal clinic for progressive decline in renal function in a span of 1.5 years. Her serum creatinine (S. Cr) was 0.86 mg/dl in January of 2023 and 1.7 mg/dl in July 2024 and later with no interim labs to compare. Lithium initiation for severe suicidal ideation was the only change in the interim with levels being closely monitored by her psychiatrist and reported to be in therapeutic range. She was also taking low dose Adderall for ADHD. She reported no polyuria or polydipsia. Further work up revealed bland urine with normal sized kidneys on renal ultrasound with no significant structural abnormalities reported. A kidney biopsy done revealed multiple small tubular cysts with chronic interstitial changes (Image 1) pointing towards Lithium induced nephrotoxicity. Lithium was promptly discontinued after discussion with her psychiatrist and her S. Cr improved from 1.9 mg /dl to 1.3 mg/dl within 4 months. Discussion: The incidence of lithium induced nephrotoxicity leading to ESKD is reported to be very low, 0.2 to 0.7%, still a staggering 8-fold increase when compared to general population. The rate of decline in eGFR is reported to be around 0.92 ml/min/1.73m2 per year of lithium treatment. While rapid decline in renal function with lithium levels being maintained in therapeutic range is rare, our case signifies the importance of maintaining high clinical suspicion and early diagnosis to prevent further decline in renal function.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025gfpyeeeg
Primary Topic
Bipolar Disorder and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chronic Lithium Use Need Not Always Be "Chronic"

Shahad Abdulameer, Kavitha Vellanki, Muhammad Sohaib Afzal
Journal of the American Society of Nephrology
Bipolar Disorder and Treatment
article

Chronic Lithium Use Need Not Always Be "Chronic"

Shahad Abdulameer, Kavitha Vellanki, Muhammad Sohaib Afzal
article en

Abstract

Introduction: Lithium induced nephropathy is typically considered to be a slowly progressive kidney disease with a reported latency period of 20 years from initiation of lithium to ESKD. Here, we present a case of progressive CKD within 2 years of initiation of lithium for bipolar disorder. Case Description: 22-year-old female with bipolar disorder and ADHD was referred to renal clinic for progressive decline in renal function in a span of 1.5 years. Her serum creatinine (S. Cr) was 0.86 mg/dl in January of 2023 and 1.7 mg/dl in July 2024 and later with no interim labs to compare. Lithium initiation for severe suicidal ideation was the only change in the interim with levels being closely monitored by her psychiatrist and reported to be in therapeutic range. She was also taking low dose Adderall for ADHD. She reported no polyuria or polydipsia. Further work up revealed bland urine with normal sized kidneys on renal ultrasound with no significant structural abnormalities reported. A kidney biopsy done revealed multiple small tubular cysts with chronic interstitial changes (Image 1) pointing towards Lithium induced nephrotoxicity. Lithium was promptly discontinued after discussion with her psychiatrist and her S. Cr improved from 1.9 mg /dl to 1.3 mg/dl within 4 months. Discussion: The incidence of lithium induced nephrotoxicity leading to ESKD is reported to be very low, 0.2 to 0.7%, still a staggering 8-fold increase when compared to general population. The rate of decline in eGFR is reported to be around 0.92 ml/min/1.73m2 per year of lithium treatment. While rapid decline in renal function with lithium levels being maintained in therapeutic range is rare, our case signifies the importance of maintaining high clinical suspicion and early diagnosis to prevent further decline in renal function.

Journal of the American Society of NephrologyVol. 36(10S)
Loyola University Medical Center (US)
Openalex Percentile: Top 56%
Bipolar Disorder and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.